Best Sacral Neuromodulation Hospitals in Israel

Rabin Medical Center provides specialised Sacral Neuromodulation with a focus on precise nerve stimulation, individualized programming, minimally invasive implantation, and long-term management of urinary or bowel dysfunction. Established in 1996, the JCI accredited hospital is located in Petah Tikva, Israel and operates 1300 beds, with modern neuromodulation, urological, colorectal, diagnostic, and rehabilitation infrastructure.

Sacral Neuromodulation can provide an effective treatment option for appropriately selected patients with refractory urinary or fecal control disorders. Treatment planning considers the underlying condition, severity and duration of symptoms, previous treatments, bladder or bowel function, neurological status, and overall health. A specialist evaluation and temporary stimulation trial help determine whether the patient is likely to benefit from permanent neuromodulation.

Choosing Sheba Medical Center for Sacral Neuromodulation gives patients access to experienced neuromodulation specialists, advanced diagnostic testing, image-guided procedures, specialized surgical facilities, and structured follow-up care. Established in 1948, the JCI accredited hospital in Ramat Gan, Israel has 1900 beds and provides specialized management of complex urinary and bowel control disorders.

Sacral Neuromodulation is generally performed in stages. During the testing phase, a small electrode is placed near the appropriate sacral nerve and connected to a stimulation system. If the patient demonstrates meaningful improvement, a permanent pulse generator may be implanted beneath the skin. Patients are monitored for pain, infection, lead displacement, changes in stimulation, or device-related complications, and the system can be programmed according to individual therapeutic needs.

Kaplan Medical Centre offers advanced Sacral Neuromodulation using modern neuromodulation and minimally invasive techniques with individualized pelvic health care plans. Established in 1953, the JCI accredited hospital is located in Rehovot, Israel and has 1100 beds, providing comprehensive urology, urogynecology, colorectal, and pelvic floor care for local and international patients.

Sacral Neuromodulation is a minimally invasive treatment that uses mild electrical impulses to stimulate the sacral nerves involved in bladder and bowel control. It may be considered for selected patients with conditions such as overactive bladder, urinary urgency incontinence, non-obstructive urinary retention, or certain forms of fecal incontinence when conservative treatments have not provided adequate relief. The therapy is delivered through a small implanted device that sends controlled electrical signals to the targeted nerves.

At Assuta Hospital, Sacral Neuromodulation is performed using specialized neuromodulation techniques and comprehensive assessment of bladder or bowel dysfunction. Established in 1934, this JCI accredited hospital in Tel Aviv, Israel has 300 beds and offers advanced urology, urogynecology, colorectal, pelvic floor, and minimally invasive treatment services.

Sacral Neuromodulation may be recommended for appropriately selected patients whose urinary or bowel symptoms persist despite other treatments. Before permanent implantation, a temporary test stimulation phase may be performed to evaluate whether symptoms improve sufficiently. During the procedure, a thin lead is positioned near the sacral nerves, typically through a small incision, and connected to an external or implanted pulse generator depending on the treatment stage.

Choosing Tel Aviv Sourasky Medical Center -Ichilov Hospital for Sacral Neuromodulation gives patients access to experienced neuromodulation specialists, advanced diagnostic testing, image-guided procedures, specialized surgical facilities, and structured follow-up care. Established in 1963, the JCI accredited hospital in Tel Aviv, Israel has 1500 beds and provides specialized management of complex urinary and bowel control disorders.

Sacral Neuromodulation is generally performed in stages. During the testing phase, a small electrode is placed near the appropriate sacral nerve and connected to a stimulation system. If the patient demonstrates meaningful improvement, a permanent pulse generator may be implanted beneath the skin. Patients are monitored for pain, infection, lead displacement, changes in stimulation, or device-related complications, and the system can be programmed according to individual therapeutic needs.